AR
VCYT icon

Advisory Research’s Veracyte VCYT Stock Holding History

Advisory Research’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-29,587
Closed -$1.59M – 386
2021
Q1 		$1.59M Buy
29,587
+15,461
+109% +$891K 0.11% 153
2020
Q4 		$691K Buy
+14,126
New +$655K 0.05% 235

Other funds holding VCYT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Advisory Research's VCYT Position: Q2 2021 in Review

Advisory Research sold out of Veracyte (VCYT) in Q2 2021, closing a stake of 29,587 shares — an estimated $1.59M sold.

Advisory Research first reported a position in VCYT in Q4 2020 and held it in 2 quarters. The position peaked at $1.59M in Q1 2021. 214 funds tracked by Wall St. Rank hold VCYT as of Q2 2021.

  • Advisory Research reported no remaining Veracyte position as of Q2 2021 after selling out during the quarter.
  • Advisory Research sold 29,587 Veracyte shares in Q2 2021, an estimated $1.59M.
  • Advisory Research first reported a position in Veracyte in Q4 2020 and held it in 2 quarters.
  • Advisory Research's Veracyte position peaked at $1.59M in Q1 2021.
  • 214 funds tracked by Wall St. Rank held Veracyte as of Q2 2021.

Based on Advisory Research's 13F filing for Q2 2021, filed 16 Aug 2021.